CrossrefInfokarte
Real-world outcomes of SGLT2 inhibitors in kidney transplant recipients with post-transplant diabetes mellitus: An effectiveness and safety analysis
Diabetes Epidemiology and Management · 2026 · 21 · 100302
DOI: 10.1016/j.deman.2026.100302 ↗Abstract
Kein Abstract verfügbar.
EUVIMED